home · filing · 0001493152-24-024424
8-K filed June 20, 2024, 7:59 PM ET
ticker SCNX
CIK 0001382574
leadership
confidence high
sentiment neutral
materiality 0.50
TRxADE Health appoints Subbarao Jayanthi to board, Narasimhan Mani resigns
Scienture Holdings, Inc.
Subbarao Jayanthi appointed to TRxADE Health board on June 17, 2024.
Jayanthi is Managing Partner of RxC International, a biopharma strategy consulting firm.
Narasimhan Mani voluntarily resigned as director on June 17, 2024, with no dispute.
Jayanthi will receive equity and cash compensation per company independent director policies.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-06-17
Filed June 20, 2024, 7:59 PM ET
On June 17, 2024, the board of directors (the “Board”) of TRxADE Health, Inc. (the “Company”) appointed Subbarao Jayanthi to the Board.
Effective 2024-06-17
Filed June 20, 2024, 7:59 PM ET
On June 17, 2024, Narasimhan Mani voluntarily resigned as a director of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Subbarao Jayanthi was appointed as Director at Scienture Holdings, Inc..
Action appointed
Role Director
Exact text from the filing
On June 17, 2024, the board of directors (the “Board”) of TRxADE Health, Inc. (the “Company”) appointed Subbarao Jayanthi to the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Narasimhan Mani resigned as Director at Scienture Holdings, Inc..
Action resigned
Role Director
Exact text from the filing
On June 17, 2024, Narasimhan Mani voluntarily resigned as a director of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-24-024424
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.